| Research Funding Opportunities to Facilitate Updating Susceptibility Test Interpretive Criteria (Breakpoints) Dear Colleagues, I would like to inform you that the FDA is accepting proposals focused on updating susceptibility test interpretive criteria (breakpoints). Specifically, research proposals focused on evaluating microbiologic, pharmacokinetic/pharmacodynamic and clinical data that could be utilized by standards development organizations and the FDA to update breakpoints (including urine-specific breakpoints) will be prioritized. Proposals should be submitted to the Broad Agency Announcement (FDABAA-22-00123; priority area 2.4.4). Information on submitting the quad chart and white paper can be found on page 33. Additional information to apply to this open announcement are linked below. Please note that the Quad Chart and White Paper are due by January 21, 2022. Please feel free to share this information with others who may be interested in applying. Thank you. | | | |
No comments:
Post a Comment